JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has a cash flow conversion efficiency ratio of 0.092x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.56 Million) by net assets ($27.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ZJYL net asset quality score to measure how much of total assets are equity-financed.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check JIN MEDICAL INTERNATIONAL LTD. Ordinary earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alcom Group Bhd
KLSE:2674
|
0.069x |
|
Alpha Group International plc
LSE:ALPH
|
-0.074x |
|
Fiplasto SA
BA:FIPL
|
-0.097x |
|
Shanyuan Co Ltd
TWO:4416
|
-0.097x |
|
PIL ITALICA LIFESTYLE LIMITED
NSE:PILITA
|
-0.035x |
|
INTERSHOP Communications Aktiengesellschaft
XETRA:ISHA
|
0.244x |
|
Crypto Blockchain Industries SA
PA:ALCBI
|
-0.428x |
|
Blue Star Gold Corp
V:BAU
|
-0.270x |
Annual Cash Flow Conversion Efficiency for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)
The table below shows the annual cash flow conversion efficiency of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see market value of JIN MEDICAL INTERNATIONAL LTD. Ordinary .
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $29.57 Million | $2.90 Million | 0.098x | +332.21% |
| 2024-09-30 | $28.55 Million | $-1.21 Million | -0.042x | -132.64% |
| 2023-09-30 | $23.98 Million | $3.11 Million | 0.130x | +24.87% |
| 2022-09-30 | $15.24 Million | $1.58 Million | 0.104x | -75.09% |
| 2021-09-30 | $14.03 Million | $5.84 Million | 0.417x | +79.75% |
| 2020-09-30 | $10.80 Million | $2.50 Million | 0.232x | +287.15% |
| 2019-09-30 | $10.71 Million | $-1.33 Million | -0.124x | +53.45% |
| 2018-09-30 | $9.00 Million | $-2.39 Million | -0.266x | -- |
About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more